Search results for: 'research area cell cycle plk'
-
P1024 IL-7, human recombinantSummary: IL-7, lymphoid cell growth factor, expressed in E.Coli, cross-species reactive. -
C3095 N-OxalylglycineSummary: cell permeable inhibitor of α-ketoglutarate-dependent enzymes, including JMJD2A, JMJD2C, and JMJD2E. -
BA1208 DCAPSummary: DCAP is a broad-spectrum antibiotic that targets the cell membranes of Gram-positive and Gram-negative bacteria. - BA1893 TucaresolSummary: Tucaresol is an orally bioavailable immune-enhancing drug that enhances T helper cell activity.
- BA7728 BOS-318Summary: BOS-318 is a potent, slowly dissociating, highly selective, inhibitor of cell permeability.
- BA5856 AcazicolceptSummary: Azacicolcept (ALPN-101), an Fc fusion protein, is a dual inducible T cell co-stimulator/antagonist.
- BA5858 SolitomabSummary: Solitomab (AMG110) is a bispecific anti- and anti-epithelial cell adhesion molecule antibody.
- BA6019 PivekimabSummary: Pivekimab is available for the study of Bastoid Plasmacytoid Dendritic Cell Neoplasms (BPDCN).
- BA6156 NSC622608Summary: NSC622608 is a T cell activation V structural domain Ig inhibitor ligand.
- BA6911 N-BromoacetamideSummary: N-Bromoacetamide irreversibly deactivates sodium channels on the cytoplasmic surface of cell membranes.